News & Analysis
- Data & Tools
- Login | Register
As the iPhone maker continues sparring with Corephotonics at PTAB and Federal Circuit, records show the camera tech battle has also spread to Chinese courts
11 November 2021
The Israeli Patent Office is considering amending the patent application procedure in line with that of the USPTO, so that applicants may file for a provisional patent application before filing a full patent application at a relatively low initial cost.
06 January 2021
While many countries are only just getting clued up about digital healthcare, Israel has long been a trailblazer in this field.
25 November 2020
In what marks a historical move for Israel and the United Arab Emirates, an Israeli company has filed a patent at the UAE Industrial Property Office for an AI-based vaccine, signalling that the two countries may work together to release technology to help combat the spread of covid-19.
04 November 2020
Breakthroughs by startups across the APAC region show the IP system is working as intended to incentivise innovation - even in a crowded patent landscape
05 September 2020
Lawsuit against the billion dollar video streaming start-up is set to keep the headline writers busy and, according to IAM analysis, could have been in the works for a long time
13 May 2020
Uncertainties persist over the protection of biological inventions and how Israeli extensions are pegged to PTEs in other countries
27 March 2020
Government responses to the pandemic could include increased focus on obligatory sharing of patented inventions, but regulatory data exclusivities might serve as a barrier in both Europe and the United States.
24 March 2020
The Israel Patent Office has denied a patent term extension for the biological drug Kovaltry, filed by Bayer Healthcare LLC. This decision clarifies the Ministry of Health’s regulatory requirements for registration of this type of drug.
19 February 2020
In Takeda Pharmaceutical Company Limited v Manufacturers Association of Israel, the Israeli Supreme Court has ruled that a pharmaceutical product's marketing approval should be considered as the first one with regard to a pharmaceutical product containing similar compounds.
12 February 2020
Get unlimited access to all IAM content